Large Cell Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Large Cell Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial of the DLL3-targeting radiopharmaceutical [212Pb]Pb-DOTAM-MAM279 (MP0712) in small cell lung cancer and other DLL…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of FZ-AD005 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 study evaluating FZ-AD005 in adults with advanced solid tumors, including small cell lung cancer and large cell neuroendoc…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) [Phase 1, Phase 2]
Phase 1/2 SKYBRIDGE study evaluating Peluntamig (PT217) in DLL3-expressing neuroendocrine carcinomas; currently recruiting.